Literature DB >> 15533859

Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.

Wojciech Wojakowski1, Michał Tendera, Anna Michałowska, Marcin Majka, Magdalena Kucia, Katarzyna Maślankiewicz, Rafał Wyderka, Andrzej Ochała, Mariusz Z Ratajczak.   

Abstract

BACKGROUND: Adult stem cells can contribute to myocardial regeneration after ischemic injury. Bone marrow and skeletal muscles contain a population of CXCR4+ cells expressing genes specific for muscle progenitor cells that can be mobilized into the peripheral blood. The aims of the study were (1) to confirm the presence of early tissue-committed cells expressing cardiac, muscle, and endothelial markers in populations of mononuclear cells in peripheral blood and (2) to assess the dynamics and magnitude of the mobilization of CD34+, CD117+, CXCR4+, c-met+, CD34/CD117+, and CD34/CXCR4+ stem cells into peripheral blood in relation to inflammatory and hematopoietic cytokines in patients with ST-segment-elevation acute myocardial infarction (STEMI). METHODS AND
RESULTS: Fifty-six patients with STEMI (<12 hours), 39 with stable angina, and 20 healthy control subjects were enrolled. Real-time reverse transcription-polymerase chain reaction (RT-PCR) was used for detection of tissue-specific markers. The number of the cells was assessed by use of a flow cytometer on admission, after 24 hours, and after 7 days. RT-PCR revealed increased expression of mRNA (up to 3.5-fold increase) for specific cardiac (GATA4, MEF2C, Nkx2.5/Csx), muscle (Myf5, Myogenin, MyoD), and endothelial (VE-cadherin, von Willebrand factor) markers in peripheral blood mononuclear cells. The number of CD34/CXCR4+ and CD34/CD117+ and c-met+ stem cells in peripheral blood was significantly higher in STEMI patients than in stable angina and healthy subjects, peaking on admission, without further significant increase after 24 hours and 7 days.
CONCLUSIONS: The study demonstrates in the setting of STEMI a marked mobilization of mononuclear cells expressing specific cardiac, muscle, and endothelial markers as well as CD34/CXCR4+ and CD34/CD117+ and c-met+ stem cells and shows that stromal cell-derived factor-1 is an important factor influencing the mobilization.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15533859     DOI: 10.1161/01.CIR.0000147609.39780.02

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  118 in total

Review 1.  Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure.

Authors:  Vincenzo Lionetti; Giacomo Bianchi; Fabio A Recchia; Carlo Ventura
Journal:  Heart Fail Rev       Date:  2010-11       Impact factor: 4.214

Review 2.  Stem cells in the infarcted heart.

Authors:  Dinender K Singla
Journal:  J Cardiovasc Transl Res       Date:  2009-11-20       Impact factor: 4.132

Review 3.  Very small embryonic-like stem cells: biology and therapeutic potential for heart repair.

Authors:  Ewa K Zuba-Surma; Wojciech Wojakowski; Mariusz Z Ratajczak; Buddhadeb Dawn
Journal:  Antioxid Redox Signal       Date:  2011-05-05       Impact factor: 8.401

4.  Comparative analysis of the predictive power of different endothelial progenitor cell phenotypes on cardiovascular outcome.

Authors:  Shmuel Schwartzenberg; Arnon Afek; Gideon Charach; Ardon Rubinstein; Yossi Ben-Shoshan; Sarina Kissil; Sofia Maisel-Auslender; Gad Keren; Jacob George
Journal:  World J Cardiol       Date:  2010-09-26

5.  Age and Human Regenerative Capacity Impact of Cardiovascular Risk Factors.

Authors:  Ibhar Al Mheid; Salim S Hayek; Yi-An Ko; Faysal Akbik; Qunna Li; Nima Ghasemzadeh; Greg S Martin; Qi Long; Muhammad Hammadah; A Maziar Zafari; Viola Vaccarino; Edmund K Waller; Arshed A Quyyumi
Journal:  Circ Res       Date:  2016-07-19       Impact factor: 17.367

Review 6.  Stem cell-based therapies in ischemic heart diseases: a focus on aspects of microcirculation and inflammation.

Authors:  Junxi Wu; Jun Li; Nannan Zhang; Cuihua Zhang
Journal:  Basic Res Cardiol       Date:  2011-03-23       Impact factor: 17.165

7.  Differential increase of CD34, KDR/CD34, CD133/CD34 and CD117/CD34 positive cells in peripheral blood of patients with acute myocardial infarction.

Authors:  F Grundmann; C Scheid; D Braun; C Zobel; H Reuter; R H G Schwinger; J Müller-Ehmsen
Journal:  Clin Res Cardiol       Date:  2007-08-13       Impact factor: 5.460

8.  Progenitor cell mobilisation in patients with acute and chronic coronary artery disease.

Authors:  A Gaspardone; F Menghini; V Mazzuca; O Skossyreva; G Barbato; P de Fabritiis
Journal:  Heart       Date:  2006-02       Impact factor: 5.994

9.  Regeneration-associated cells improve recovery from myocardial infarction through enhanced vasculogenesis, anti-inflammation, and cardiomyogenesis.

Authors:  Amankeldi A Salybekov; Akira T Kawaguchi; Haruchika Masuda; Kosit Vorateera; Chisa Okada; Takayuki Asahara
Journal:  PLoS One       Date:  2018-11-28       Impact factor: 3.240

Review 10.  The critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.

Authors:  S Gelmini; M Mangoni; M Serio; P Romagnani; E Lazzeri
Journal:  J Endocrinol Invest       Date:  2008-09       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.